J. Boot et al.38
worked on a novel arylthiomethyl morpholines, a potent selective norepinephrine
reuptake inhibitors (NERIs) and dual serotonin/ norepinephrine reuptake
inhibitors (SRI/NERIs). The target compounds were prepared using a
stereochemically versatile synthesis featuring an aldol condensation as the key
step. One enantiomer of the 2-methoxy-substituted analogue was found to be a
potent and selective norepinephrine reuptake inhibitor, whereas the opposite
enantiomer was a potent dual serotonin/norepinephrine reuptake inhibitor. Reaction between
benzaldehyde and the enolate derived from readily available N-benzyl-2-morpholinone (34) gave an acceptable yield of the two
diastereomeric benzylalcohols (35)
and (36) in a ratio of 2.2/1 (Scheme 10).39 The aldol products
could be separated by chromatography on silica gel. The assignment of relative
stereochemistry was based on the coupling constants between the proton at C-2
of the morpholine ring and the benzylic hydrogen. The initial assignment of the
relative stereochemistry was later confirmed by X-ray crystallographic analysis.40 Diborane-mediated
reduction of the lactam gave morpholine benzyl alcohols (37) and (38) in good yield.
________________________
38. J. Boot,
M. Cases, B. P. Clark, J. Findlay, P. T. Gallagher, L. Hayhurst, T. Man, C.
Montalbetti, R. E. Rathmell, H. Rudyk, M. W. Walter, M. Whatton, and V. Wood, Bioorg. Med. Chem. Lett., 2005, 15, 699.
39. A. Dobrev,
L. Nechev, and K. Ivanov, Liebigs Ann. Chem., 1989, 815.
40. For details see: M. W. Walter, B. P. Clark, P.
T. Gallagher, H. L. Haughton, and H. C. E. Rudyk, WO 2004017977NET assay: J. Gobel,
D. L. Saussy, and A. Goetz, J. Pharmacol.Toxicol. Methods, 1999, 42, 237;
SERT/DAT assay: S. Ramamoorthy, E. Giovanetti, Y. Qian, and R. Blakely, J. Biol. Chem., 1998, 273, 2458.
Next Page
Next Page